Elizabeth Dao1,2, Ging-Yuek Robin Hsiung2,3, Vesna Sossi4, Roger Tam5,6, Elham Shahinfard4, Eloise Nicklin2, Walid Al Keridy2,3, Teresa Liu-Ambrose1,2,7. 1. Department of Physical Therapy, University of British Columbia (UBC), Vancouver, Canada. 2. Djavad Mowafaghian Centre for Brain Health, Vancouver Coastal Health Research Institute, Vancouver, Canada. 3. Division of Neurology, UBC, Vancouver, Canada. 4. Department of Physics and Astronomy, UBC, Vancouver, Canada. 5. Department of Radiology, UBC, Vancouver, Canada. 6. School of Biomedical Engineering, UBC, Vancouver, Canada. 7. Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, Canada.
Abstract
BACKGROUND:Impaired physical function (i.e., slowing of gait, muscle weakness, and poor mobility) is common in older adults with cognitive impairment and dementia. Evidence suggests that cerebral small vessel disease, specifically white matter lesions (WMLs), is associated with impaired physical function, but little research has been conducted to understand the specific role of Alzheimer's disease pathology in physical outcomes. OBJECTIVE: The objective of this study was to examine the association between cerebral amyloid-β (Aβ) deposition and physical function in people with cognitive impairment. METHODS:Thirty participants completed an11C Pittsburgh compound B (PIB) position emission tomography (PET) scan to quantify global Aβ deposition using standardized uptake value ratio (SUVR). We assessed usual gait speed, muscle strength of the lower extremities, balance, and functional mobility using the Short Physical Performance Battery (SPPB) and the Timed Up and Go Test (TUGT). Multiple linear regression analyses examined the association between Aβ and each measure of physical function, adjusting for age, body mass index, and WML load. RESULTS:Global PIB SUVR was significantly associated with usual gait speed (β= -0.52, p = 0.01) and SPPB performance (β= -0.47, p = 0.02), such that increased Aβ deposition was associated with reduced performance on both measures. Global PIB SUVR was not significantly associated with TUGT performance (β= 0.32, p = 0.08). CONCLUSIONS: Cerebral Aβ deposition is associated with reduced gait speed, muscle strength, and balance in older adults with cognitive impairment independent of WML load. However, Aβ deposition was not associated with functional mobility.
RCT Entities:
BACKGROUND: Impaired physical function (i.e., slowing of gait, muscle weakness, and poor mobility) is common in older adults with cognitive impairment and dementia. Evidence suggests that cerebral small vessel disease, specifically white matter lesions (WMLs), is associated with impaired physical function, but little research has been conducted to understand the specific role of Alzheimer's disease pathology in physical outcomes. OBJECTIVE: The objective of this study was to examine the association between cerebral amyloid-β (Aβ) deposition and physical function in people with cognitive impairment. METHODS: Thirty participants completed an 11C Pittsburgh compound B (PIB) position emission tomography (PET) scan to quantify global Aβ deposition using standardized uptake value ratio (SUVR). We assessed usual gait speed, muscle strength of the lower extremities, balance, and functional mobility using the Short Physical Performance Battery (SPPB) and the Timed Up and Go Test (TUGT). Multiple linear regression analyses examined the association between Aβ and each measure of physical function, adjusting for age, body mass index, and WML load. RESULTS: Global PIB SUVR was significantly associated with usual gait speed (β= -0.52, p = 0.01) and SPPB performance (β= -0.47, p = 0.02), such that increased Aβ deposition was associated with reduced performance on both measures. Global PIB SUVR was not significantly associated with TUGT performance (β= 0.32, p = 0.08). CONCLUSIONS: Cerebral Aβ deposition is associated with reduced gait speed, muscle strength, and balance in older adults with cognitive impairment independent of WML load. However, Aβ deposition was not associated with functional mobility.
Entities:
Keywords:
Alzheimer’s disease; amyloid-βzzm321990; mild cognitive impairment; mobility; physical function
Authors: Ryan J Dougherty; Janani Ramachandran; Fangyu Liu; Yang An; Amal A Wanigatunga; Qu Tian; Murat Bilgel; Eleanor M Simonsick; Luigi Ferrucci; Susan M Resnick; Jennifer A Schrack Journal: Alzheimers Dement (Amst) Date: 2021-08-20
Authors: Marijn Muurling; Hanneke F M Rhodius-Meester; Juha Pärkkä; Mark van Gils; Kristian S Frederiksen; Marie Bruun; Steen G Hasselbalch; Hilkka Soininen; Sanna-Kaisa Herukka; Merja Hallikainen; Charlotte E Teunissen; Pieter Jelle Visser; Philip Scheltens; Wiesje M van der Flier; Jussi Mattila; Jyrki Lötjönen; Casper de Boer Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Maria H Nilsson; Gro Gujord Tangen; Sebastian Palmqvist; Danielle van Westen; Niklas Mattsson-Carlgren; Erik Stomrud; Oskar Hansson Journal: J Gerontol A Biol Sci Med Sci Date: 2021-03-31 Impact factor: 6.053